Huntington Disease and Tourette Syndrome. II. Uptake of Glutamic Acid and Other Amino Acids by Fibroblasts
Overview
Authors
Affiliations
Injection of kainic acid, a rigid analog of the excitatory neurotransmitter glutamic acid (glu), into the neostriatum of rats produces a condition that mimics Huntington disease (HD) in at least 12 different morphological and biochemical parameters. These results suggested that one of the possible basic mechanisms in HD is a defect in the presynaptic of glial uptake of glu, resulting in chronic hyperstimulation and death of a specific set of neurons. To test this hypothesis, the uptake of glu was studied in 12 carefully matched sets of control-HD pairs and two lines of Tourette syndrome fibroblasts. Although the first six sets suggested a glutamate transport defect in HD cells, examination of 12 sets indicated that there were no significant differences between control and HD cells. The fibroblasts showed both a high and low affinity uptake of glutamic acid. Sodium dependent uptake of L-glutamate (L-glu) minus D-glutamate (D-glu) at 100, 1,000, and 10,000 Micrometers glutamate was normal in HD and Tourette syndrome cells.
Of mice, rats and men: Revisiting the quinolinic acid hypothesis of Huntington's disease.
Schwarcz R, Guidetti P, Sathyasaikumar K, Muchowski P Prog Neurobiol. 2009; 90(2):230-45.
PMID: 19394403 PMC: 2829333. DOI: 10.1016/j.pneurobio.2009.04.005.
The ups and downs of Huntington disease research.
Comings D Am J Hum Genet. 1981; 33(2):314-7.
PMID: 6452061 PMC: 1684937.
The current state of research with peripheral tissues in Huntington disease.
Beverstock G Hum Genet. 1984; 66(2-3):115-31.
PMID: 6325322 DOI: 10.1007/BF00286586.
Huntington disease: genetics and epidemiology.
Conneally P Am J Hum Genet. 1984; 36(3):506-26.
PMID: 6233902 PMC: 1684448.